Meeting
2022 ASCO Annual Meeting
Survival outcomes following colorectal cancer surgery in low- and middle-income countries: A systematic review.
Authors
Tom M. Diehl
University of Wisconsin Hospitals and Clinics, Madison, WI
Tom M. Diehl , Adel H. Khan , Nabiha Akhlaq Mughal , Daniel T. Schroeder , Sheida Pourdashti , Leslie Christensen , Sadaf Khan , Syed Nabeel Zafar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 3544)
DOI
10.1200/JCO.2022.40.16_suppl.3544
Abstract #
3544
Poster Bd #
338
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Clinical relevance of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma who underwent surgery following neoadjuvant modified FOLFIRINOX.
First Author: So Heun Lee
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Benefit of immune checkpoint inhibitors (ICI) for patients with advanced esophageal squamous cell carcinoma and low PD-L1 expression: A systematic review and meta-analysis.
First Author: Mario Machado Lopes
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Neoadjuvant chemotherapy vs upfront resection: A challenging choice in resectable pancreatic ductal adenocarcinoma.
First Author: Fatemeh Fekrmandi
Poster
2023 ASCO Annual Meeting
Neoadjuvant docetaxel, oxaliplatin, and s-1 plus surgery and adjuvant s-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial.
First Author: Yoon-Koo Kang